The FDA has issued a warning that transmucosal buprenorphine products may cause tooth decay, cavities, oral infections, and tooth loss. The federal agency said it has identified 305 cases of dental problems that were associated with buprenorphine tablets and films that dissolve under the tongue or against the inside of the cheek.
